Cofsky, Joshua C. http://orcid.org/0000-0001-5403-8555
Soczek, Katarzyna M. http://orcid.org/0000-0003-3803-6079
Knott, Gavin J. http://orcid.org/0000-0002-9007-6273
Nogales, Eva http://orcid.org/0000-0001-9816-3681
Doudna, Jennifer A. http://orcid.org/0000-0001-9161-999X
Article History
Received: 2 November 2021
Accepted: 1 March 2022
First Online: 14 April 2022
Competing interests
: The Regents of the University of California have patents issued and/or pending for CRISPR technologies on which G.J.K. and J.A.D. are inventors. J.A.D. is a cofounder of Caribou Biosciences, Editas Medicine, Scribe Therapeutics, Intellia Therapeutics and Mammoth Biosciences. J.A.D. is a scientific advisory board member of Vertex, Caribou Biosciences, Intellia Therapeutics, eFFECTOR Therapeutics, Scribe Therapeutics, Mammoth Biosciences, Algen Biotechnologies, Synthego, Algen Biotechnologies, Felix Biosciences, The Column Group, and Inari. J.A.D. is Chief Science Advisor to Sixth Street, a Director at Johnson & Johnson, Altos and Tempus, and has research projects sponsored by Biogen, Pfizer, Apple Tree Partners, and Roche. The remaining authors declare no competing interests.